Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020
Go back to Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020| Gilead Sciences (NASDAQ: GILD) | Delayed: 121.67 -3.83 (3.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.50 | 52 Week High | $108.63 | |||
| Open | $125.64 | 52 Week Low | $71.39 | |||
| Day High | $125.64 | P/E | 67.22 | |||
| Day Low | $121.57 | EPS | $1.81 | |||
| Volume | 5,363,283 | |||||

